Literature DB >> 33620119

Tumor suppressive microRNA-485-5p targets PRRX1 in human skin melanoma cells, regulating epithelial-mesenchymal transition and apoptosis.

Xiaolin Wu1,2, Haiying Bao1.   

Abstract

Melanoma is one of the most aggressive skin cancers. Existing evidence has reported the aberrant expression of microRNAs (miRNAs) in melanoma, but their putative targets and underlying downstream effects remain to be further understood. Herein, we explored the suppressive role of miR-485-5p in melanoma progression. Initial bioinformatics analyses showed that the PRRX1 gene was differentially expressed in melanoma, while miR-485-5p was predicted to be a potential regulatory miRNA binding to PRRX1 mRNA. We confirmed that PRRX1 was upregulated, while miR-485-5p was downregulated in human melanoma samples compared with adjacent normal skin tissues. We then showed that PRRX1 was a target gene of miR-485-5p by dual-luciferase reporter gene assay. Moreover, a reduction in the expression of PRRX1 and downregulation of important proteins of the transforming growth factor-beta (TGFβ) signaling pathway was observed after miR-485-5p overexpression. Furthermore, miR-485-5p overexpression or PRRX1 knockdown suppressed epithelial-mesenchymal transition, cell viability, migration, and invasion, and promoted cell apoptosis in melanoma cells. Our study demonstrates the tumor-suppressive functions of miR-485-5p in the development of human melanoma, providing a potential target for therapy.
© 2021 International Federation for Cell Biology.

Entities:  

Keywords:  melanoma; microRNA-485-5p; paired related homeobox 1; transforming growth factor-beta signaling pathway

Mesh:

Substances:

Year:  2021        PMID: 33620119     DOI: 10.1002/cbin.11575

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  3 in total

1.  Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival.

Authors:  Alberto Vázquez-Naharro; José Bustos-Tauler; Alfredo Floristán; Lourdes Yuste; Sara S Oltra; Antònia Vinyals; Gema Moreno-Bueno; Àngels Fabra; Francisco Portillo; Amparo Cano; Patricia G Santamaría
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

2.  PRRX1 Is a Novel Prognostic Biomarker and Facilitates Tumor Progression Through Epithelial-Mesenchymal Transition in Uveal Melanoma.

Authors:  Zhishang Meng; Yanzhu Chen; Wenyi Wu; Bin Yan; Lusi Zhang; Huihui Chen; Yongan Meng; Youling Liang; Xiaoxi Yao; Jing Luo
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

Review 3.  The Regulatory Role of PRRX1 in Cancer Epithelial-Mesenchymal Transition.

Authors:  Wenjiao Du; Xinchang Liu; Man Yang; Weipeng Wang; Jing Sun
Journal:  Onco Targets Ther       Date:  2021-07-16       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.